Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer;”
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
ClinicalTrials.gov study NCT00058058. IPD Sharing: Not stated. Countries: 3. Publications: 3.
eHealth Weight Loss Program in African American Breast Cancer Survivors
ClinicalTrials.gov study NCT02699983. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Study With the Trifunctional Antibody Ertumaxomab to Treat Metastatic Breast Cancer After Progression on Trastuzumab Therapy
ClinicalTrials.gov study NCT00522457. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
ClinicalTrials.gov study NCT00703326. IPD Sharing: YES. Countries: 23. Publications: 3.
Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
ClinicalTrials.gov study NCT02187991. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial
ClinicalTrials.gov study NCT00752986. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Correlation of Predictive Accuracy of PREDICT Version 2.2 of Indian Women With Operable Breast Cancer
ClinicalTrials.gov study NCT04985253. IPD Sharing: NO. Countries: 1. Publications: 17.
Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer
ClinicalTrials.gov study NCT03137693. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer
ClinicalTrials.gov study NCT01828021. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4]
ClinicalTrials.gov study NCT02297438. IPD Sharing: YES. Countries: 5. Publications: 2.
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
ClinicalTrials.gov study NCT01029925. IPD Sharing: Not stated. Countries: 1. Publications: 9.
Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
ClinicalTrials.gov study NCT00379197. IPD Sharing: Not stated. Countries: 1. Publications: 1.
HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast Cancer
ClinicalTrials.gov study NCT02165605. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer
ClinicalTrials.gov study NCT03901339. IPD Sharing: YES. Countries: 9. Publications: 8.
GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00320411. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
ClinicalTrials.gov study NCT00334542. IPD Sharing: NO. Countries: 1. Publications: 2.
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
ClinicalTrials.gov study NCT00374322. IPD Sharing: Not stated. Countries: 33. Publications: 3.
A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)
ClinicalTrials.gov study NCT01120184. IPD Sharing: Not stated. Countries: 38. Publications: 3.
A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breas
ClinicalTrials.gov study NCT04622319. IPD Sharing: YES. Countries: 31. Publications: 1.
A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool
ClinicalTrials.gov study NCT01840163. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.